Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of Bosaya vs Prolia in Healthy Volunteers
NCT05323708Phase 1Completed
- Sponsor
- Biocon
- Start
- Mar 2022
- Primary completion
- Oct 2023
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of DenOsteoRel in osteoporosis (2 arms), sponsored by Biocon. Primary endpoints: Area Under the Concentration-time curve from time zero to infinity, Area Under the Concentration-time curve from time zero to the last measurable concentration and 1 more. Started Mar 2022; status: completed.
02
Drugs
DenOsteoRel
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT05323708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05323708.